Safety and Targeting of Anti-hk2 Antibody in mCRPC

Clinical trial NCT04116164 · TERMINATED

Trial details

NCT number: NCT04116164
Sponsor: SpectronRX
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Castration-Resistant Prostatic Cancer Metastatic Disease

Start date: 2019-09-18
Primary completion: 2023-07-06
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.